Shanghai Fourier Intelligence signed an MoU with ETH Zurich on January 13 to consolidate their collaboration on research about rehabilitation robotics and clinical care.
Shanghai robotics startup signed MoU on sidelines of industry summit to update its rehabilitation technology
Shanghai, January 13, 2020 – Shanghai Fourier Intelligence, an emerging global leader in rehabilitation robotics, has announced the signing of a memorandum of understanding (MoU) with Sensory-Motor Systems Lab at ETH Zurich, a topnotch research institution in Switzerland.
The MoU came on the heels of the Global Rehabilitation & Assistive Technology Network Summit (or GReAT Summit) chiefly organised by the Shanghai-based startup, which was founded in 2015.
Professor Robert Riener, director of the Sensory-Motor Systems Lab at ETH Zurich, one of the top five Polytechnique universities across Europe, and Associated professor Denny Oetomo, head of the Fourier Intelligence-University of Melbourne Joint Lab, put pen to paper at the signing ceremony.
The MoU came as the Shanghai tech company has been aggressively reaching out to leading world hospitals and academic bodies over the past few years in hopes of conducting joint research in rehabilitation robotics technology.
According to Zen Koh, Fourier Intelligence Co-founder, Group Deputy CEO and Chief Strategy Officer, details of the MoU have been finalised several months ago, pending official announcement during the GReAT Summit.
The MoU will give a new impetus to the long-standing academic ties between the two sides. It could see both parties start to test and optimise the EXOPS (Exoskeleton & Robotics Open Platform System) and the upper extremity rehabilitation robotics ArmMotus M2 Pro. Fourier Intelligence will supply the devices to ETH Zurich.
“One (of our areas of cooperation) is the further development, use and test of the X2,” says Professor Riener. “The other is with the upper extremity robotics, because we have rich experience with upper extremity rehabilitation.”
He added the access he has to clinics could also help entitle Fourier Intelligence products to tests by patients.
Associate professor Denny Oetomo from the University of Melbourne applauded the MoU, saying this could set the stage for new collaboration, starting perhaps with ” visits to each other’s labs.”
Over time, a bigger focus will be on examining exoskeleton techniques being used in labs. “(At ETH Zurich) They have very well integrated engineering and clinical testing,” he says.
The two sides are also recruiting two full-time researchers at ETH Zurich to help with the joint lab project.
“There have yet to be concrete steps toward commercialisation as collaboration with ETH is purely about research,” Associated professor Oetomo claims.
About Fourier Intelligence
Fourier Intelligence is a technology-driven company, infusing creativity into the development of exoskeleton and rehabilitation robotics since 2015. Together with researchers, therapists and patients, we aim to excel in developing and redefining rehabilitation robotics solutions with interconnectable intelligent robotics technology by elevating user experience with an intuitive, easy-to-use system to enhance the lives of both patients and therapists.
For investor and media inquiries, please contact:
Mr Zen Koh (Co-founder/Deputy CEO/Chief Strategy Officer)